Neutral
Apogee Therapeutics (APGE) CFO sells 2,000 shares under 10b5-1 plan
Apogee Therapeutics, Inc.'s CFO, Jane Henderson, sold 2,000 shares of common stock at $90.00 per share on April 16, 2026, totaling $180,000. This tran...